Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akram Khan

Showing results (211-220 of 257) with videos related to

Pageof 26
Sort By:
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022Noah Kojima, Katherine Adams, Wesley H Self, et al.
The Journal of Infectious Diseases|April 8, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial VirusKevin C Ma, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 8, 2024
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, et al.
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021Mark W Tenforde, Samantha M Olson, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Pageof 26

Showing results (211-220 of 257) with videos related to

Sort By:
Pageof 26
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022Noah Kojima, Katherine Adams, Wesley H Self, et al.
The Journal of Infectious Diseases|April 8, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial VirusKevin C Ma, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 8, 2024
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, et al.
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021Mark W Tenforde, Samantha M Olson, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Pageof 26